
Susanne Meis
@susanne_meis
ID: 712239366769348608
22-03-2016 11:27:52
88 Tweet
37 Followers
129 Following

SELUTION DeNovo is the largest DCB RCT (n>3300 pts) looking into Strategy of treatment with DCB vs latest generation DES & powered for superiorty of DCB strategy at 5 years. #SELUTIONSLR MedAlliance Swiss Medical Technology clinicaltrials.gov/ct2/show/NCT04โฆ

BIG #ANNOUNCEMENT! Weโre excited to announce our acquisition of MedAlliance Swiss Medical Technology, a Switzerland-based medical technology company pioneering key innovations for coronary and peripheral arterial disease. More information below! #Cordis #FreetoImagine cordis.com/na/news


We're delighted to announce that we have entered an acquisition agreement with ๐๐ผ๐ฟ๐ฑ๐ถ๐. Our SELUTION SLRโข, will provide a flagship product which will complement Cordis' existing product portfolio. View press release below: medalliance.com/2022/10/18/medโฆ #MedAlliance #Cordis


Use IVUS Sahil A. Parikh, MD Sanjay Divakaran Beau Hawkins,MD Peter Monteleone, MD, FACC, FSCAI kenneth rosenfield Sabeen Dhand ๐๐พ๐๐พBT Fisher Sr., MD Kumar Madassery JACC Journals David Chalyan, MD, MSc DR MICHAEL R JAFF Hady Lichaa, MD, FACC, FSCAI, FSVM, RPVI Kush Desai John Rundback, MD Sean Lyden The VIVA Foundation jacc.org/doi/10.1016/j.โฆ


Susanne Meis SELUTION DeNovo @Rana_Saitta MedAlliance Swiss Medical Technology Dr Peter O'Kane Tom Johnson CERC_CRO Dragica Paunovic A truly important trial set to change how we do PCI. Delighted to have the chance to be involved


The very first US patient has been enrolled in the SELUTION4ISR IDE study paving the way to bring #selutionSLR sirolimus -eluting Balloon to the US patients with coronary disease! To read the full press release: bit.ly/3JxkmhJ #SELUTION4ISR #DCB #DEB



SELUTION DeNovo Dr Peter O'Kane A great day - thanks everyone



Rota-DCB-Concept prevented 100mm DES in this patient. Symptome free after 12 months routine follow-up. โฆStรฉphane Rinfret, MD SMโฉ โฆLorenzo Azzaliniโฉ โฆPCRonline ๐ซโฉ โฆAGIKโฉ โฆCardiovascular Research Foundationโฉ โฆGregg W. Stone MDโฉ โฆDr Roxana Mehranโฉ โฆZiad Aliโฉ

Excited to announce the enrollment of over 1,000 patients in our ground-breaking SELUTION DeNovo coronary randomized clinical trial ! For the full press release: bit.ly/3ldhD2Z #SELUTIONSLR #clinicaltrials #medicaldevices #DCB #DEB CERC_CRO Simon eccleshall Philip Urban


Here we go! #Cordis and MedAlliance Swiss Medical Technology teams are ready to welcome you today for this new #EuroPCR edition in #Paris! Booth setup โ Training Village setup โ Motivated & enthusiastic teammates โ #RediscoverCordis #MedicalDevices #Cardiology #coronaryarterydisease #CAD #DCB #DEB


๐ซ๐ทHow would you treat? Latest trends in PCI โ Stentless PCI & the role of sustained limus release #SelutionDeNovo got prime time today at #EuroPCR2023 Simon eccleshall CERC_CRO Antoinette Neylon, Florian Krackhardt, Dr Peter O'Kane, Christian Spaulding, Philip Urban


Small six years ago when we presented our first drug coated balloon (DCB) PPCI experience #EuroPCR, what a journey! Simon eccleshall Tash Corballis ClintMaart Alisdair Ryding Sreekumar Sulfi Vass Vassiliou Mamas A. Mamas


SELUTION DeNovo: designed to change medical practice Next Milestone โ congratulations and thanks to all investigators that made this happen. @Rana_Saitta Simon eccleshall Philip Urban newswire.ca/news-releases/โฆ
